- Home
- GERN vs LMB Comparison
GERN vs LMB Comparison
Compare GERN & LMB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | GERN | LMB |
|---|---|---|
| Founded | 1990 | 1901 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Engineering & Construction |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 753.3M | 857.4M |
| IPO Year | 1996 | 2014 |
Fundamental Metrics
Financial Performance| Metric | GERN | LMB |
|---|---|---|
| Price | $1.38 | $78.26 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 7 | 2 |
| Target Price | $3.00 | ★ $144.00 |
| AVG Volume (30 Days) | ★ 6.8M | 152.1K |
| Earning Date | 11-05-2025 | 11-04-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 39.03 |
| EPS | N/A | ★ 3.03 |
| Revenue | $183,403,000.00 | ★ $603,582,000.00 |
| Revenue This Year | $147.34 | $28.00 |
| Revenue Next Year | $39.11 | $13.48 |
| P/E Ratio | ★ N/A | $25.39 |
| Revenue Growth | ★ 522.13 | 16.56 |
| 52 Week Low | $1.04 | $63.02 |
| 52 Week High | $4.05 | $154.05 |
Technical Indicators
Market Signals| Indicator | GERN | LMB |
|---|---|---|
| Relative Strength Index (RSI) | 64.29 | 52.50 |
| Support Level | $1.21 | $73.00 |
| Resistance Level | $1.42 | $76.80 |
| Average True Range (ATR) | 0.07 | 3.48 |
| MACD | 0.02 | 1.69 |
| Stochastic Oscillator | 85.48 | 82.58 |
Price Performance
Historical ComparisonAbout GERN Geron Corporation
Geron Corp is a clinical-stage biopharmaceutical company focused on the research and development of cancer treatments. The company's drug in development, Imelstat, is being tested for the treatment of myelodysplastic syndromes, which are disorders of the blood, and myelofibrosis, which is a rare blood cancer affecting bone marrow. The company earns revenue through collaboration agreements, milestones, royalties, and licensing arrangements. Geron possesses various rights to this drug. The company operates as a single segment being, the development of therapeutic products for oncology.
About LMB Limbach Holdings Inc.
Limbach Holdings Inc is a commercial specialty contractor in the fields of heating, ventilation, air conditioning, plumbing, electrical, and building controls for the design and construction of new and renovated buildings, maintenance services, energy retrofits, and equipment upgrades. It operates in two segments namely General Contractor Relationships (GCR) and Owner Direct Relationships (ODR). The company generates maximum revenue from the ODR segment.